As FDA approval of the first postpartum depression drug hits the news, study looks at how infant fussiness and a baby’s level of prematurity may influence the severity of maternal depressive symptoms.
Mothers of fussy babies at higher risk of depressive symptoms
As FDA approval of the first postpartum depression drug hits the news, study looks at how infant fussiness and a baby’s level of prematurity may influence the severity of maternal depressive symptoms.